| [1]Hawkes JE, Yan BY. Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis. 2018; 201(6): 1605-1613.[2]Capon F. The Genetic Basis of Psoriasis.Int J Mol Sci.2017;18(12).[3]Langley RG,Elewski BE,Lebwohl M,et al.Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med.2014;371(4): 326-338.[4]Zollner TM, Renz H,Igney FH, et al.Animal models of T-cell-mediated skin diseases. Bioessays.2004; 26(6): 693-696.[5]Groves RW, Mizutani H, Kieffer JD, et al.Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A.1995; 92(25): 11874-11878.[6]Shepherd J,Little MC,Nicklin MJ.Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist.J Invest Dermatol.2004; 122(3): 665-669.[7]Nakajima A,Matsuki T,Komine M,et al.TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.J Immunol.2010;185(3): 1887-1893.[8]Milora KA,Fu H,Dubaz O,et al.Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1. J Invest Dermatol. 2015;135(12):2992-3000..[9]Bullard DC,Scharffetter-Kochanek K,Mcarthur MJ, et al.A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.Proc Natl Acad Sci U S A.1996;93(5): 2116-2121.[10]Chang BY,Zhao F,He X,et al.JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.J Immunol. 2009;183(3): 2183-2192.[11]Johnston A, Fritz Y, Dawes SM, et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.J Immunol.2013; 190(5): 2252-2262.[12]Croxford AL,Karbach S,Kurschus FC,et al.IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.J Invest Dermatol.2014;134(3): 728-735.[13]Karbach S, Croxford AL,Oelze M,et al.Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol. 2014;34(12): 2658-2668.[14]Li AG, Wang D, Feng XH, et al. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. Embo J.2004;23(8): 1770-1781.[15]Li F, Bian L,Iriyama S, et al.Smad7 Ameliorates TGF-β-Mediated Skin Inflammation and Associated Wound Healing Defects but Not Susceptibility to Experimental Skin Carcinogenesis.J Invest Dermatol. 2019;139(4):940-950.[16]Sano S,Chan KS,Carbajal S,et al.Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.Nat Med.2005;11(1): 43-49.[17]Takaishi M,Ishizaki M,Suzuki K,et al.Oral administration of a novel RORgammat antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17. J Dermatol Sci.2017;85(1): 12-19.[18]Nakajima K, Kataoka S, Sato K, et al. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production. J Dermatol Sci. 2019;93(2):82-91.[19]Xia YP, Li B,Hylton D,et al.Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.Blood. 2003;102(1): 161-168.[20]Chen T,Zhang LW,Fu LX, et al. Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse.Clin Exp Dermatol.2017; 42(8): 849-856.[21]Stratis A,Pasparakis M,Rupec RA, et al.Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest.2006;116(8): 2094-2104.[22]Gatzka M, Hainzl A, Peters T, et al. Reduction of CD18 promotes expansion of inflammatory gammadelta T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.J Immunol.2013; 191(11): 5477-5488.[23]Zenz R,Eferl R,Kenner L,et al.Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature.2005; 437(7057): 369-375.[24]Schon MP. Animal models of psoriasis: a critical appraisal.Exp Dermatol. 2008;17(8): 703-712.[25]Danilenko D M. Review paper: preclinical models of psoriasis.Vet Pathol. 2008;45(4): 563-575.[26]Peuhu E, alomaa SI,De Franceschi N,et al.Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.2017;12(10): e0186628.[27]Hogenesch H,Gijbels MJ,Offerman E,et al.A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.Am J Pathol.1993;143(3): 972-982.[28]郭政宏,周彪,唐冬梅,等.新型小分子化合物对银屑病模型小鼠尾部鳞片颗粒层细胞的影响[J].生命科学研究, 2016, 20(4): 340-344.[29]Van Der Fits L, Mourits S, Voerman JS, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.J Immunol.2009;182(9): 5836-5845.[30]Moos S, Mohebiany AN, Waisman A, et al.Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Invest Dermatol. 2019 ;23. pii: S0022-202X(19)30022-3. [31]张海婧,周琬琪,张翼,等. 十二烷基硫酸钠诱导银屑病动物模型的建立[J].武警医学,2013,24(5): 373-375.[32]Ji M,Xue N,Lai F,et al.Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment. Biol Pharm Bull.2018；41(4): 592-596.[33]Wolf R,Shechter H, Brenner S. Induction of psoriasiform changes in guinea pig skin by propranolol. Int J Dermatol.1994; 33(11): 811-814.[34]Yao N, Xia JX, Liu XM, et al. Topical application of a new monoclonal antibody against fibroblast growth factor 10 (FGF 10) mitigates propranolol-induced psoriasis-like lesions in guinea pigs.Eur Rev Med Pharmacol Sci.2014;18(7): 1085-1091.[35]樊丹采. 基于血瘀证的银屑病机制初探[D]. 广州:广州中医药大学, 2016.[36]Chan JR,Blumenschein W,Murphy E,et al.IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.J Exp Med.2006;203(12): 2577-2587.[37]施惠娟,周茹,金少举,等. 氧化苦参碱对银屑病模型雌激素周期小鼠阴道上皮细胞增殖和凋亡的影响[J]. 临床皮肤科杂志, 2011,40(11): 669-672.[38]Di Domizio J, Conrad C, Gilliet M. Xenotransplantation Model of Psoriasis. Methods Mol Biol.2017; 1559: 83-90.[39]Gilhar A,David M,Ullmann Y,et al. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice.J Invest Dermatol.1997; 109(3): 283-288.[40]郭姗姗,郭菲,刘红霞.银屑病模型与脾虚证银屑病病证结合模型的实验研究[C].南京：2012全国中西医结合皮肤性病学术会议, 2012.[41]郭菲. 健脾解毒汤对脾虚证银屑病豚鼠模型的实验研究[D]. 乌鲁木齐:新疆医科大学, 2012.[42]周萌, 伍秋云, 陈会茹. 银屑病血瘀证动物模型的构建探讨[C].上海: 2010全国中西医结合皮肤性病学术会议, 2010.[43]王玉芝. 银屑病湿热证动物模型的构建[J]. 山东中医杂志, 2013, 32(7): 489-490.[44]郭菲,刘红霞. 银屑病脾虚证豚鼠模型构建初探[J]. 中国实验方剂学杂志, 2012,18(15): 242-245.[45]Boukamp P,Petrussevska RT,Breitkreutz D,et al.Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.J Cell Biol.1988; 106(3): 761-771.[46]Martin G, Guerard S, Fortin M M, et al.Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact. Lab Invest.2012;92(7): 1058-1070.[47]Van Den Bogaard EH,Tjabringa GS,Joosten I,et al.Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases. J Invest Dermatol.2014;134(3): 719-727.[48]Kim Y,Park N,Rim YA,et al.Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells. Stem Cell Res Ther.2018;9(1): 217.[49]Berg EL,Yang J,Melrose J,et al.Chemical target and pathway toxicity mechanisms defined in primary human cell systems. J Pharmacol Toxicol Methods.2010;61(1): 3-15.[50]Greb JE,Goldminz AM,Elder JT,et al.Psoriasis.Nat Rev Dis Primers. 2016;2: 16082.[51]Wang X, Sun J, Hu J. IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation. PLoS One. 2015;10(12): e0145498. |
.jpg)
文题释义：
回交实验：是子一代与它两个亲本中的任一个亲本进行杂交的一种实验方法。回交实验对于性状遗传的研究有重要的意义，特别是使用隐性亲本进行回交，是检验其子一代基因型的有效方法。
中医病证结合动物模型：一种包含了特定的现代医学疾病元素与中医“证”的元素的复合动物模型。为了让动物模型更加体现中医的证候特色，相关领域的学者在单纯的疾病动物的研究模型基础上，加入中医的“证”的相应内容，创建“病证结合”的动物模型。目前病证结合动物模型研究较多，尚有待规范化。
.jpg)
.jpg)
文题释义：
回交实验：是子一代与它两个亲本中的任一个亲本进行杂交的一种实验方法。回交实验对于性状遗传的研究有重要的意义，特别是使用隐性亲本进行回交，是检验其子一代基因型的有效方法。
中医病证结合动物模型：一种包含了特定的现代医学疾病元素与中医“证”的元素的复合动物模型。为了让动物模型更加体现中医的证候特色，相关领域的学者在单纯的疾病动物的研究模型基础上，加入中医的“证”的相应内容，创建“病证结合”的动物模型。目前病证结合动物模型研究较多，尚有待规范化。